India's doctors raise alarm over unregulated weight-loss injections
Doctors in India are worried about the growing, unregulated use of popular weight-loss injections like Mounjaro, Wegovy, and Ozempic.
Originally meant for diabetes, these drugs are now increasingly available as more people look for ways to manage weight.
With diabetes and obesity numbers soaring, the GLP-1 drug market is booming—Mounjaro became India's highest-selling drug within eight months of its approval for sale in April 2025.
Why should you care?
These meds might sound like an easy answer, but experts warn they're not risk-free—side effects can include muscle loss and even serious health issues if taken without proper medical guidance.
Some gyms and pharmacies are handing them out without specialist advice, which worries doctors.
As cheaper generics roll out soon, access will only get easier—so knowing the risks (and that lifestyle changes still matter) is more important than ever for anyone thinking about these injections.